Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Sonrotoclax and BCMA Bispecific Antibody in Newly Diagnosed Systemic AL Amyloidosis Based on t(11;14) Genetic Stratification

NCT07687004

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Not Yet Recruiting

Family-Focused Study to Support Medication for Opioid Use Disorder

NCT07451197

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

University of Wisonsin-Madison Madison, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

NCT07684274

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

NCT07665450

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

NCT07684950

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

NCT07682792

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

Hospital Based Continuous Patient Monitoring System

NCT06739447

Conditions: Appendectomy, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

NCT07681596

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Research Site Duarte, California, United States

Research Site Denver, Colorado, United States

Research Site Tampa, Florida, United States

Research Site Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

NCT07514819

Conditions: Bone Diseases, Bone Neoplasms, Bone Tumor, +24 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not Yet Recruiting

Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL：Stop Trial 2.0

NCT07682415

Conditions: CLL / SLL, Chronic Disease, Disease Attributes, +14 more
Locations: Shenzhen Second People's Hospital Shenzhen, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions